Sudeep Pharma IPO 2025: Price Band, Dates, Allotment, Issue Size & Full Review

The much-anticipated Sudeep Pharma IPO is set to open on 21st November 2025, offering investors an opportunity to invest in one of India’s leading manufacturers of excipients and speciality ingredients. With a strong global presence and a diversified product portfolio, the company is gearing up for a significant market debut.

Below is the complete breakdown of Sudeep Pharma IPO details, including issue size, price range, schedule, company overview, strengths, risks, and more.

---

⭐ Sudeep Pharma IPO Details

---

📅 Sudeep Pharma IPO Schedule

---

🏢 About Sudeep Pharma

Founded in 1989, Sudeep Pharma has evolved from a basic excipients manufacturer to a technology-driven global supplier of excipients, mineral-based ingredients, and speciality formulations. The company caters to pharmaceutical, food, and nutrition industries with a wide product portfolio of 100+ ingredients.

Sudeep Pharma specializes in:

• Mineral-based ingredients – Calcium, Magnesium, Potassium, Iron, Zinc

• Micronutrient premixes

• Encapsulated formulations

• Spray-dried and granulated products

• Liposomal preparations

The company operates three advanced manufacturing facilities in Vadodara, Gujarat, with a combined capacity of 65,579 MT. It holds global certifications including USFDA, WHO-GMP, and ISO, serving more than 1,100 customers across 100 countries.

Major clients include:
Pfizer, Merck Group, Danone, and other Fortune 500 companies.

---

💰 Sudeep Pharma IPO Issue Size Breakdown

---

🧾 Utilisation of IPO Proceeds

---

💪 Strengths of Sudeep Pharma

• Strong R&D capabilities boosting innovation and new product development.

• Leadership team with decades of industry expertise.

• Globally compliant facilities with high scalability.

• Trusted by blue-chip and Fortune 500 companies worldwide.

• Market leader in a high-entry-barrier ingredient segment.

• Wide product portfolio and long-term customer relationships.

---

⚠️ Risks to Consider

• Over 35% revenue from top 10 customers → concentration risk.

• More than 60% business comes from one segment.

• Quality issues or certification failures can impact global orders.

• All manufacturing units located in Gujarat, creating location-dependent risks.

• Delays in product launches may affect growth.

• Acquisitions may not always deliver expected synergies.

• Regulatory delays may disrupt operations and exports.

---

📝 How to Check Sudeep Pharma IPO Allotment Status

You can check your allotment status using the registrar’s website.

Steps:

1. Visit the MUFG Intime India IPO Allotment Status page.

2. Select Sudeep Pharma from the dropdown list.

3. Enter any of the following:

   • PAN

   • Application Number

   • DP/Client ID

   • Bank Account Number / IFSC

4. Click Submit to view your allotment result.

---

📌 Conclusion

The Sudeep Pharma IPO looks promising for investors seeking exposure to the growing pharmaceutical ingredients and excipients market. With global certifications, strong customer relationships, and consistent demand for speciality ingredients, the company holds strong potential. However, investors should also consider concentration risks and regulatory sensitivities before investing.

Related Post :

PhonePe IPO 2025: Price Band, Dates, GMP, Review & Full Details